Health Care·Biotechnology·$28.9B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.46 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.46 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed a cautious optimism about future growth opportunities. They are focused on expanding their market presence and improving efficiency.
Management highlighted ongoing investments in R&D to drive future growth.
They emphasized the importance of expanding their customer base.
There was a focus on improving operational efficiency.
Natera's earnings report showed a loss per share of $0.46, but there was no revenue data available. The stock reacted negatively, declining by 0.69%. This suggests that investors may be concerned about the lack of concrete revenue figures and future guidance, despite management's optimistic outlook on growth and efficiency improvements.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ONEOK INC NEW
Feb 24, 2020